It's a good quarterly as the 30%+ growth is the best quarterly growth (YoY) since Q1 FY17.
Operating cash flow:
Q4 FY17: -5.8
Q4 FY18: 1.5m (7.3m improvement)
I think the more pertinent question is how is this NOT a good quarterly?
FY18 overall is a different story though. It has been nothing special..a pass mark IMO (at best).
However breaking it down...the H1 results were very disappointing with only 14% revenue growth. Poor results in North America and XOS which had negative growth were two key reasons. They spoke about restructuring this and the results speak for themselves. 19% growth for the FY, so H2 growth in the mid 20's. XOS turned from negative into a 9% YoY revenue uplift. Clearly the changes they made there have been productive.
The key for me is I feel the momentum is shifting, clearly shown by the much stronger H2 results. I would be thinking much differently if the H1 & H2 results were the other way around.
Add in the great work you can see occurring through PLAYR (worth following on Instagram) and I think FY19 will be a positive one.
Subscription mix is important but the overall revenue and growth is far more important. CAT have a sticky product, as long as their subscription mix doesn't go down i'll be comfortable.
All IMO, please DYOR.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
It's a good quarterly as the 30%+ growth is the best quarterly...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.42 |
Change
0.030(0.88%) |
Mkt cap ! $638.2M |
Open | High | Low | Value | Volume |
$3.41 | $3.51 | $3.34 | $5.142M | 1.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $3.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.47 | 6413 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.980 |
1 | 4986 | 0.970 |
1 | 1036 | 0.965 |
2 | 32659 | 0.960 |
2 | 41512 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 1 | 1 |
1.000 | 42518 | 3 |
1.010 | 10000 | 1 |
1.020 | 25000 | 1 |
1.040 | 18507 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online